DMAC vs IP · $157.4M cap vs P/E 43, $26.62B cap
DiaMedica Therapeutics Inc (DMAC) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
DMAC does not have a complete income-statement cache yet.
IP does not have a complete income-statement cache yet.
DMAC currently screens at market cap $157.4M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the DMAC and IP stock pages for the full models.
Not investment advice.